Literature DB >> 17309564

Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells.

H Yu1, X Zhao, S Huang, L Jian, G Qian, S Ge.   

Abstract

The Notch proteins constitute a family of transmembrane receptors that play a pivotal role in cellular differentiation, proliferation, and apoptosis. RNA interference of Presenilin1 (PS1) and Notch1 was carried out in this research to determine whether it could block Notch signaling and induce growth inhibition in HeLa cells. We transfected synthesized target small interfering RNA (siRNA) into HeLa cells, and blocking of Notch signaling was detected by C-promoter binding factor-1 (CBF1) reporter. We then conducted cell proliferation assay. Cells transfected with PS1 and Notch1 siRNA showed great inhibition in proliferation compared to the controls in vitro and in vivo. We conclude that RNA interference of PS1 or Notch1 can block Notch signaling and consequently induce growth inhibition of HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309564     DOI: 10.1111/j.1525-1438.2007.00813.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.

Authors:  Laura G Franko-Tobin; L Vienna Mackey; Wei Huang; Xiangwei Song; Baofeng Jin; Jing Luo; Lynsie M Morris; Minqiu Liu; Joseph A Fuselier; David H Coy; Lizi Wu; Lichun Sun
Journal:  Oncologist       Date:  2012-01-30

2.  Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

Authors:  Mingyi Wang; Jian Wang; Lin Wang; Liying Wu; Xiaoyan Xin
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

3.  Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.

Authors:  He Zhang; Haibo Wang; Jianjun Zhang; Guanxiang Qian; Beibei Niu; Xianqun Fan; Jian Lu; Andrew R Hoffman; Ji-Fan Hu; Shengfang Ge
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

4.  Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.

Authors:  Xiaolin Huang; Li Wang; He Zhang; Haibo Wang; Xiaoping Zhao; Guanxiang Qian; Jifan Hu; Shengfang Ge; Xianqun Fan
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

5.  Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.

Authors:  Lichun Sun; Mingqiu Liu; Guang-Chun Sun; Xu Yang; Qingqing Qian; Shuyu Feng; L Vienna Mackey; David H Coy
Journal:  J Cancer       Date:  2016-06-30       Impact factor: 4.207

6.  A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors.

Authors:  Yuting Yao; Li Wang; He Zhang; Haibo Wang; Xiaoping Zhao; Yidan Zhang; Leilei Zhang; Xianqun Fan; Guanxiang Qian; Ji-Fan Hu; Shengfang Ge
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

7.  Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy.

Authors:  Elenaé Vázquez-Ulloa; Ana Clara Ramos-Cruz; Diddier Prada; Alejandro Avilés-Salas; Alma Delia Chávez-Blanco; Luis A Herrera; Marcela Lizano; Adriana Contreras-Paredes
Journal:  Oncotarget       Date:  2018-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.